Epigenetic dysregulation in cognitive disorders

被引:107
|
作者
Graeff, Johannes
Mansuy, Isabelle M. [1 ]
机构
[1] Univ Zurich, Brain Res Inst, Fac Med, Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
epigenetic codes; neurodegeneration; neurodevelopment; reversibility; schizophrenia; RUBINSTEIN-TAYBI-SYNDROME; HISTONE DEACETYLASE INHIBITORS; LONG-TERM-MEMORY; DNA METHYLATION; MOUSE MODEL; HUNTINGTONS-DISEASE; SYNAPTIC PLASTICITY; ACETYLTRANSFERASE ACTIVITY; GENETIC-HETEROGENEITY; ALZHEIMERS-DISEASE;
D O I
10.1111/j.1460-9568.2009.06787.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epigenetic mechanisms are not only essential for biological functions requiring stable molecular changes such as the establishment of cell identity and tissue formation, they also constitute dynamic intracellular processes for translating environmental stimuli into modifications in gene expression. Over the past decade it has become increasingly clear that both aspects of epigenetic mechanisms play a pivotal role in complex brain functions. Evidence from patients with neurodegenerative and neurodevelopmental disorders such as Alzheimer's disease and Rett syndrome indicated that epigenetic mechanisms and chromatin remodeling need to be tightly controlled for proper cognitive functions, and their dysregulation can have devastating consequences. However, because they are dynamic, epigenetic mechanisms are also potentially reversible and may provide powerful means for pharmacological intervention. This review outlines major cognitive disorders known to be associated with epigenetic dysregulation, and discusses the potential of 'epigenetic medicine' as a promising cure.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [21] Senescence and epigenetic dysregulation in cancer
    Neumeister, P
    Albanese, C
    Balent, B
    Greally, J
    Pestell, RG
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (11): : 1475 - 1490
  • [22] Epigenetic dysregulation in pituitary tumors
    Shariq, Omair A.
    Lines, Kate E.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2019, 6 (03)
  • [23] Epigenetic dysregulation in hematological malignancies
    Atsushi Iwama
    International Journal of Hematology, 2017, 105 : 5 - 6
  • [24] Epigenetic dysregulation in hematological malignancies
    Iwama, Atsushi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (01) : 5 - 6
  • [25] Epigenetic dysregulation in thyroid neoplasia
    Kondo, Tetsuo
    Asa, Sylvia L.
    Ezzat, Shereen
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (02) : 389 - +
  • [26] Epigenetic dysregulation in follicular lymphoma
    Araf, Shamzah
    Okosun, Jessica
    Koniali, Lola
    Fitzgibbon, Jude
    Heward, James
    EPIGENOMICS, 2016, 8 (01) : 77 - 84
  • [27] Epigenetic Dysregulation in the Schizophrenic Brain
    Halene T.B.
    Peter C.J.
    Akbarian S.
    Current Behavioral Neuroscience Reports, 2014, 1 (2) : 86 - 93
  • [28] Does dysregulation of key epigenetic and biochemical pathways occur in postulated vasoactive neuropeptide autoimmune disorders?
    Staines, DR
    MEDICAL HYPOTHESES, 2005, 65 (06) : 1154 - 1160
  • [29] Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders
    Zhu, Li
    Wang, Xiaoming
    Li, Xin-Lei
    Towers, Aaron
    Cao, Xinyu
    Wang, Ping
    Bowman, Rachel
    Yang, Hyuna
    Goldstein, Jennifer
    Li, Yi-Ju
    Jiang, Yong-Hui
    HUMAN MOLECULAR GENETICS, 2014, 23 (06) : 1563 - 1578
  • [30] Epigenetic dysregulation of Oxtr in Tet1-deficient mice has implications for neuropsychiatric disorders
    Towers, Aaron J.
    Tremblay, Martine W.
    Chung, Leeyup
    Li, Xin-Lei
    Bey, Alexandra L.
    Zhang, Wenhao
    Cao, Xinyu
    Wang, Xiaoming
    Wang, Ping
    Duffney, Lara J.
    Siecinsk, Stephen K.
    Xu, Sonia
    Kim, Yuna
    Kong, Xiangyin
    Gregory, Simon
    Xie, Wei
    Jiang, Yong-Hui
    JCI INSIGHT, 2018, 3 (23)